Table 1.

Assessment Measures

Assessment Schedule

Year 1

Month

Screen

BL1/0

BL2/0

1

2

3

4

5

6

7

8

9

10

11

12

PROCEDURE

On-Site Assessments

IRB-approved Informed Consent Form

X

Screening Form (In-/Exclusion)

X

Demographics and Psychiatric History

X

Medical History & Current Medication

X

SURF-Monthly24

X

P

P

X

P

P

X

P

P

P

P

P

X

SURF-Quarterly

X

X

X

P

X

Antipsychotic Medication Adherence Assessment

X

X

X

X

Prescription Medication Experience

X

X

X

X

Self-Report Assessment Form

X

X

X

X

Annual Demographic Update

X

Intent to Attend Form25

X

X

X

X

Family Assessment Scale

X

X

X

Client Recovery Outcomes

X

X

X

Physical Assessment (Sitting and standing blood pressure, sitting and standing pulse, Weight, BMI, Waist Circumference, temperature, EPS, akathisia, and abnormal involuntary movements)

X

X

X

X

Cognition BACS26

X

X

Laboratory Tests - lipid panel, metabolic profile, HbA1C and fasting insulin levels

X

X

X

X

Urbanicity Questionnaire27

X

Remote Telemedicine –

SCID – DSM-IV

X

X

Psychopathology (PANSS/CGI/CDSS)

X

X

X

Functional Outcome (QLS)

X

X

X

Year 2

Month

13

14

15

16

17

18

19

20

21

22

23

24

PROCEDURE

On-Site Assessments

SURF-M

P

P

P

P

P

X

P

P

P

P

P

X

SURF-Q

P

X

P

X

Antipsychotic Medication Adherence Assessment

X

X

Prescription Medication Experience

X

X

Self-Report Rating Form

X

X

Intent to Attend Form

X

Annual Demographic Update

X

Family Assessment Scale

X

X

Client Recovery Outcomes

X

X

Physical Assessment (Sitting and standing blood pressure, sitting and standing pulse, Weight, BMI, Waist Circumference, temperature, EPS, akathisia, and abnormal involuntary movements)

X

X

Cognition (BACS)

X

Laboratory Tests - lipid panel, metabolic profile, HbA1C and fasting insulin levels

X

X

Remote Telemedicine – SedAvante

Psychopathology (PANSS/CGI/CDSS)

X

X

Functional Outcome (QLS)

X

X

Year 3

Month

25

26

27

28

29

30

31

32

33

34

35

36

PROCEDURE

On-Site Assessments

SURF-M

P

P

P

P

P

X

P

P

P

P

P

X

SURF-Q

P

X

P

X

Antipsychotic Medication Adherence Assessment

X

X

Prescription Medication Experience

X

X

Self-Report Rating Form

X

X

Annual Demographic Update

X

Intent to Attend Form

X

Family Assessment Scale

X

X

Client Recovery Outcomes

X

X

Physical Assessment (Sitting and standing blood pressure, sitting and standing pulse, Weight, BMI, Waist Circumference, temperature, EPS, akathisia, and abnormal involuntary movements)

X

X

Laboratory Tests - lipid panel, metabolic profile, HbA1C and fasting insulin levels

X

X

Remote Telemedicine – MedAvante

Psychopathology (PANSS/CGI/CDSS)

X

X

Functional Outcome (QLS)

X

X

Year 4

Month

37

38

39

40

41

42

43

44

45

46

47

48

PROCEDURE

On-Site Assessments

SURF-M

P1

P1

P1

P1

P1

X

P1

P1

P1

P1

P1

X

SURF-Q

P1

X

P1

X

Antipsychotic Medication Adherence Assessment

X

X

Prescription Medication Experience

X

X

Self-Report Rating Form

X

X

Annual Demographic Update

X

Intent to Attend Form

X

Family Assessment Scale

X

X

Client Recovery Outcomes

X

X

Physical Assessment (Sitting and standing blood pressure, sitting and standing pulse, Weight, BMI, Waist Circumference, temperature, EPS, akathisia, and abnormal involuntary movements)1

X

X

Laboratory Tests - lipid panel, metabolic profile, HbA1C and fasting insulin levels1

X

X

Remote Telemedicine – MedAvante

Psychopathology (PANSS/CGI/CDSS)

X

X2

Functional Outcome (QLS)

X

X

Year 5

Month

54

60

PROCEDURE

On-Site Assessments

SURF-M

X

X

SURF-Q

X

X

Client Status Update

X

X

Physical Assessment (Sitting and standing blood pressure, sitting and standing pulse, Weight, BMI, Waist Circumference, temperature, EPS, akathisia, and abnormal involuntary movements)1

X

X

Laboratory Tests - lipid panel, metabolic profile, HbA1C and fasting insulin levels1

X

X

Remote Telemedicine –Assessments

Psychopathology (PANSS)

X

X

Functional Outcome (QLS)

X

X

P= Phone Interview; X=In person Assessment; AIM = Abnormal Involuntary Movements; BACS= Brief Assessment of Cognition in Schizophrenia; CDSS=Calgary Depression Scale for Schizophrenia; CGI=Clinical Global Impressions; EPS = Extrapyramidal symptoms; PANSS=Positive and Negative Syndrome Scale; QLS=Quality of Life Scale; SCID=Structured Clinical Interview for DSM-IV Axis I Disorders; SURF-M and Q =Service Utilization and Resources Form for Schizophrenia

P= Phone Interviews; X=In person Interviews; AIM= Abnormal Involuntary Movements; BACS= Brief Assessment of Cognition in Schizophrenia; BARS=Brief Adherence Rating Scale; CDSS=Calgary Depression Scale for Schizophrenia; EPS= Extrapyramidal symptoms; CGI=Clinical Global Impressions; PANSS=Positive and Negative Syndrome Scale; QLS=Quality of Life Scale; SURF-M and Q =Service Utilization and Resources Form for Schizophrenia

P= Phone Interviews; X=In person Interviews; AIM= Abnormal Involuntary Movements; BACS= Brief Assessment of Cognition in Schizophrenia; BARS=Brief Adherence Rating Scale; CDSS=Calgary Depression Scale for Schizophrenia; EPS= Extrapyramidal symptoms; CGI=Clinical Global Impressions; PANSS=Positive and Negative Syndrome Scale; QLS=Quality of Life Scale; SURF-M and Q =Service Utilization and Resources Form for Schizophrenia

P= Phone Interviews; X=In person Interviews; AIM= Abnormal Involuntary Movements; BACS= Brief Assessment of Cognition in Schizophrenia; BARS=Brief Adherence Rating Scale; CDSS=Calgary Depression Scale for Schizophrenia; EPS= Extrapyramidal symptoms; CGI=Clinical Global Impressions; PANSS=Positive and Negative Syndrome Scale; QLS=Quality of Life Scale; SURF-M and Q =Service Utilization and Resources Form for Schizophrenia

¹=Data only collected for a subset of participants

²=PANSS only

P= Phone Interviews; X=In person Interviews; PANSS=Positive and Negative Syndrome Scale; QLS=Quality of Life Scale; SURF-M and Q =Service Utilization and Resources Form for Schizophrenia

¹= Data only collected for a subset of participants